1. Home
  2. CDT vs CETX Comparison

CDT vs CETX Comparison

Compare CDT & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • CETX
  • Stock Information
  • Founded
  • CDT 2019
  • CETX 1998
  • Country
  • CDT United States
  • CETX United States
  • Employees
  • CDT N/A
  • CETX N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • CETX EDP Services
  • Sector
  • CDT Health Care
  • CETX Technology
  • Exchange
  • CDT Nasdaq
  • CETX Nasdaq
  • Market Cap
  • CDT 3.1M
  • CETX 3.5M
  • IPO Year
  • CDT N/A
  • CETX 1998
  • Fundamental
  • Price
  • CDT $2.15
  • CETX $3.04
  • Analyst Decision
  • CDT
  • CETX
  • Analyst Count
  • CDT 0
  • CETX 0
  • Target Price
  • CDT N/A
  • CETX N/A
  • AVG Volume (30 Days)
  • CDT 57.3K
  • CETX 132.2K
  • Earning Date
  • CDT 11-14-2025
  • CETX 12-29-2025
  • Dividend Yield
  • CDT N/A
  • CETX N/A
  • EPS Growth
  • CDT N/A
  • CETX N/A
  • EPS
  • CDT N/A
  • CETX N/A
  • Revenue
  • CDT N/A
  • CETX $76,095,551.00
  • Revenue This Year
  • CDT N/A
  • CETX $19.77
  • Revenue Next Year
  • CDT N/A
  • CETX $15.00
  • P/E Ratio
  • CDT N/A
  • CETX N/A
  • Revenue Growth
  • CDT N/A
  • CETX 16.50
  • 52 Week Low
  • CDT $1.61
  • CETX $2.63
  • 52 Week High
  • CDT $2,198.40
  • CETX $57.90
  • Technical
  • Relative Strength Index (RSI)
  • CDT 47.44
  • CETX 38.79
  • Support Level
  • CDT $1.61
  • CETX $2.63
  • Resistance Level
  • CDT $2.84
  • CETX $3.42
  • Average True Range (ATR)
  • CDT 0.21
  • CETX 0.44
  • MACD
  • CDT -0.08
  • CETX -0.16
  • Stochastic Oscillator
  • CDT 39.19
  • CETX 15.27

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: